| pubmed-article:19664245 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19664245 | lifeskim:mentions | umls-concept:C0033809 | lld:lifeskim |
| pubmed-article:19664245 | lifeskim:mentions | umls-concept:C0002499 | lld:lifeskim |
| pubmed-article:19664245 | lifeskim:mentions | umls-concept:C0004521 | lld:lifeskim |
| pubmed-article:19664245 | lifeskim:mentions | umls-concept:C0007559 | lld:lifeskim |
| pubmed-article:19664245 | lifeskim:mentions | umls-concept:C0009316 | lld:lifeskim |
| pubmed-article:19664245 | lifeskim:mentions | umls-concept:C1516022 | lld:lifeskim |
| pubmed-article:19664245 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:19664245 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:19664245 | pubmed:dateCreated | 2009-9-7 | lld:pubmed |
| pubmed-article:19664245 | pubmed:abstractText | There are limited choice of antimicrobial agents to treat infection with metallo-beta-lactamase-producing Pseudomonas aeruginosa. We evaluate the antimicrobial effects of aztreonam alone, colistin alone and the 3-drug combination of aztreonam, ceftazidime and amikacin on 23 strains of metallo-beta-lactamase-producing P. aeruginosa by time-killing tests. | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19664245 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19664245 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19664245 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19664245 | pubmed:issn | 1471-2334 | lld:pubmed |
| pubmed-article:19664245 | pubmed:author | pubmed-author:YamamotoMasay... | lld:pubmed |
| pubmed-article:19664245 | pubmed:author | pubmed-author:OieShigeharuS | lld:pubmed |
| pubmed-article:19664245 | pubmed:author | pubmed-author:KamiyaAkiraA | lld:pubmed |
| pubmed-article:19664245 | pubmed:author | pubmed-author:MasudaYukiY | lld:pubmed |
| pubmed-article:19664245 | pubmed:author | pubmed-author:FukuiYumiY | lld:pubmed |
| pubmed-article:19664245 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19664245 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:19664245 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19664245 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19664245 | pubmed:pagination | 123 | lld:pubmed |
| pubmed-article:19664245 | pubmed:dateRevised | 2010-9-27 | lld:pubmed |
| pubmed-article:19664245 | pubmed:meshHeading | pubmed-meshheading:19664245... | lld:pubmed |
| pubmed-article:19664245 | pubmed:meshHeading | pubmed-meshheading:19664245... | lld:pubmed |
| pubmed-article:19664245 | pubmed:meshHeading | pubmed-meshheading:19664245... | lld:pubmed |
| pubmed-article:19664245 | pubmed:meshHeading | pubmed-meshheading:19664245... | lld:pubmed |
| pubmed-article:19664245 | pubmed:meshHeading | pubmed-meshheading:19664245... | lld:pubmed |
| pubmed-article:19664245 | pubmed:meshHeading | pubmed-meshheading:19664245... | lld:pubmed |
| pubmed-article:19664245 | pubmed:meshHeading | pubmed-meshheading:19664245... | lld:pubmed |
| pubmed-article:19664245 | pubmed:meshHeading | pubmed-meshheading:19664245... | lld:pubmed |
| pubmed-article:19664245 | pubmed:meshHeading | pubmed-meshheading:19664245... | lld:pubmed |
| pubmed-article:19664245 | pubmed:meshHeading | pubmed-meshheading:19664245... | lld:pubmed |
| pubmed-article:19664245 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19664245 | pubmed:articleTitle | In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa. | lld:pubmed |
| pubmed-article:19664245 | pubmed:affiliation | Department of Pharmacy, Yamaguchi University Hospital, Ube, Japan. oie-ygc@umin.ac.jp | lld:pubmed |
| pubmed-article:19664245 | pubmed:publicationType | Journal Article | lld:pubmed |
